Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5294 | 1577 | 36.8 | 70% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEPHROTOXICITY | Author keyword | 45 | 12% | 23% | 361 |
2 | SERV FARMACOL TOSSICOL | Address | 21 | 90% | 1% | 9 |
3 | CISPLATIN NEPHROTOXICITY | Author keyword | 21 | 65% | 1% | 20 |
4 | IST ANAL TECNOL FARMACEUT | Address | 6 | 100% | 0% | 4 |
5 | CISPLATIN INDUCED NEPHROTOXICITY | Author keyword | 5 | 60% | 0% | 6 |
6 | BETAMIPRON | Author keyword | 4 | 67% | 0% | 4 |
7 | CISPLATIN PROCAINE COMPLEX | Author keyword | 4 | 75% | 0% | 3 |
8 | UNCHANGED CISPLATIN | Author keyword | 4 | 75% | 0% | 3 |
9 | SEZ PATOL GEN ONCOL SPERIMENTALE | Address | 3 | 57% | 0% | 4 |
10 | N BENZOYL BETA ALANINE | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INDUCED NEPHROTOXICITY | 57 | 23% | 14% | 221 |
2 | CIS PLATINUM NEPHROTOXICITY | 38 | 71% | 2% | 30 |
3 | PLATINUM NEPHROTOXICITY | 35 | 74% | 2% | 26 |
4 | REDOX STATE UNBALANCE | 18 | 89% | 1% | 8 |
5 | RENAL CORTICAL SLICES | 15 | 43% | 2% | 27 |
6 | MANNITOL DIURESIS | 11 | 65% | 1% | 11 |
7 | INDUCED HYPOMAGNESEMIA | 11 | 54% | 1% | 14 |
8 | GLUTATHIONE PROTECTION | 10 | 73% | 1% | 8 |
9 | DIAMMINEDICHLORIDE | 8 | 60% | 1% | 9 |
10 | INDUCED KIDNEY | 6 | 80% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies | 2008 | 382 | 143 | 62% |
Cisplatin nephrotoxicity: A review | 2007 | 328 | 78 | 67% |
Mechanisms of Cisplatin Nephrotoxicity | 2010 | 130 | 200 | 54% |
Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity | 2009 | 139 | 124 | 57% |
Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update | 2012 | 43 | 183 | 49% |
Cisplatin nephrotoxicity | 2003 | 323 | 39 | 56% |
Membrane Transporters as Mediators of Cisplatin Side-effects | 2014 | 11 | 32 | 31% |
Mitochondrial dysregulation and protection in cisplatin nephrotoxicity | 2014 | 5 | 57 | 54% |
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity | 2011 | 29 | 177 | 47% |
Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research | 2006 | 90 | 91 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERV FARMACOL TOSSICOL | 21 | 90% | 0.6% | 9 |
2 | IST ANAL TECNOL FARMACEUT | 6 | 100% | 0.3% | 4 |
3 | SEZ PATOL GEN ONCOL SPERIMENTALE | 3 | 57% | 0.3% | 4 |
4 | UKT MED 2 | 2 | 36% | 0.3% | 5 |
5 | FUNCT FOODS NUTRACEUT PHYTOMED UNIT | 2 | 67% | 0.1% | 2 |
6 | PHARMACOLGY TOXICOL | 2 | 67% | 0.1% | 2 |
7 | SERV MODELLI ANIM | 2 | 67% | 0.1% | 2 |
8 | UNITA FARMACOL TOSSICOL | 2 | 67% | 0.1% | 2 |
9 | FARMACOL TOSSICOL | 2 | 40% | 0.3% | 4 |
10 | CELL TUMOUR BIOL | 2 | 43% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189441 | CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R |
2 | 0.0000112784 | LIPOSOMAL CISPLATIN//LIPOPLATIN//SPI 077 |
3 | 0.0000110885 | OTOTOXICITY//CISPLATIN OTOTOXICITY//OTOPROTECTION |
4 | 0.0000100138 | CYSPLATIN//FLUORESCENT METHODS//ADRIABLASTIN |
5 | 0.0000084435 | CISPLATIN RESISTANCE//PLATINUM DNA ADDUCTS//HUMAN OVARIAN CANCER CELL LINE |
6 | 0.0000081026 | WEN PI TANG//CEPHALORIDINE//WEN PI TANG HAB WU LING SAN |
7 | 0.0000076309 | DALTONS LYMPHOMA//FK 565//POLY PLAT |
8 | 0.0000066690 | INTRAPERITONEAL CHEMOTHERAPY//INTRAPERITONEAL//INTRAPERITONEAL THERAPY |
9 | 0.0000062457 | GENTAMICIN//GENTAMICIN INDUCED NEPHROTOXICITY//GENTAMICIN NEPHROTOXICITY |
10 | 0.0000058917 | PLATINUM BASED DRUG//JM216//PLATINUM COMPLEXES |